Accueil > Actualité
Actualite financiere : Actualite bourse

GSK: Japan approves new HIV two-drug pill

( - GlaxoSmithKline has won approval to sell its once-daily, single-pill, two-drug regimen treatment of HIV in Japan, the world's second-biggest pharmaceutical market, the drugmaker said on Wednesday.

GSK's ViiV Healthcare has obtained approval of Dovato from the Japan Ministry of Health, Labour and Welfare for the treatment of HIV-1 infection, to be administered orally, it said.

The standard of care in Japan for people living with HIV has been with a three-drug regimen for many years.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.